This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
Grady JL, Gencher J, Adrianowycz S and Martinez-Romero G (2024) Clinical remission of cutaneous lymphoma in a dog treated with verdinexor. Journal of the American Animal Hospital Association60, 223-226
London C, Bernabe LF, Barnard S et al. (2013) Evaluation of the novel, orally bioavailable selective inhibitor of nuclear export (SINE) verdinexor (KPT-335) in spontaneous canine cancer: results of phase I and phase II clinical trials. Blood122, 5149
Mullin C, Clifford CA and Johannes CM (2024) New therapies in veterinary oncology. Veterinary Clinics of North America: Small Animal Practice54, 469–476
Sadowski AR, Gardner HL, Borgatti A et al. (2018) Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma. BMC Veterinary Research14, 250
Thamm DH (2024) Novel treatments for lymphoma. Veterinary Clinics of North America: Small Animal Practice54, 477–490
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
